24
17
th
CoNGRESS oF THE EuRoPEAN SoCiETy FoR SEXuAL MEdiCiNE
Scientific Program l
Friday, 6 February 2015
RT-16
iNduSTRy SPoNSoREd RouNd TABLE
16:00–17:15
Auditorium 15
see page 54
RT-09
RouNd TABLE
16:00–17:15
Auditorium 10/11
Is there a future for medical therapy of Peyronie‘s
disease?
Chairs: Fulvio Colombo, Italy
Ilan Efraim Gruenwald, Israel
001
Pathophysiology of Peyronie‘s disease: How can
we easily identify new treatment targets?
William Stebbeds, United Kingdom
002
Mechanisms of penile fibrosis and the potential
of No / cGMP pathway modulation in Peyronie‘s
disease
nestor Gonzalez-Cadavid, USA
003
oral therapy for Peyronie‘s disease: What we
should prescribe and what we should not pre-
scribe. That‘s the question!!
Hartmut Porst, Germany
004
Local and intralesional therapy for Peyronie‘s
disease is a mainstay in the future
Anthony J. Bella, Canada
RT-10
RouNd TABLE
16:00–17:15
Auditorium 12
neurotransmitters, mood regulation and sexual behavior
Chairs: Kerstin Fugl-Meyer, Sweden
Marcel D. Waldinger, The netherlands
001
Neurotransmitters in female sexual function and
dysfunction
Tillmann Krüger, Germany
002
Mood, psychotic disorders and sleep disorders
– how do they affect sexuality?
Michael Lew Starowicz, Poland
003
Psychopharmacology and sexual function – good
or bad?
Annamaria Giraldi, Denmark
ESSM ANNuAL BuSiNESS MEETiNG
17:30–18:30
Auditorium 15
– for members only –
